ClinicalMetric / Countries / Sweden / breast cancer
← 🇸🇪 Sweden Trials
🇸🇪 Sweden Country × Condition

breast cancer Clinical Trials in Sweden

Active clinical trials for breast cancer with research sites in Sweden. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇸🇪 Sweden

Active Trials in Sweden (2)

NCT06340516
Recruiting

NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity

Enrollment
700 pts
Country
🇸🇪 Sweden
Vastra Gotaland Region
View Trial →
NCT06195865
Recruiting

Autologous vs. Implant-based Breast Reconstruction

Enrollment
250 pts
Country
🇸🇪 Sweden
Vastra Gotaland Region
View Trial →

Frequently Asked Questions

How many breast cancer clinical trials are active in Sweden?
There are currently 2 active clinical trials for breast cancer with sites in Sweden, of which 2 are actively recruiting patients.
How can I join a breast cancer clinical trial in Sweden?
To join a breast cancer clinical trial in Sweden, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Sweden directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast cancer trials in Sweden?
Active breast cancer trials in Sweden span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Sweden Trials → Global breast cancer Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology